Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Buchman, A. S.
Right arrow Articles by Klawans, H. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Buchman, A. S.
Right arrow Articles by Klawans, H. L.
NEUROLOGY 1988;38:527
© 1988 American Academy of Neurology

Hemiparkinsonism with hemiatrophy

Aron S. Buchman, MD, Christopher G. Goetz, MD and Harold L. Klawans, MD

From the Department of Neurological Sciences, Rush-Presbyterian-St. Lukes Medical Center, Chicago, IL

We studied fifteen patients with hemiparkinsonism and ipsilateral hemiatrophy (HP/HA) to better characterize the clinical features of this syndrome and its rate of progression. Patients were distinguished by highly asymmetric parkinsonism with predominant signs on the side of HA, early age of onset (43. 7 years versus 60. 2 years in our control population of idiopathic Parkinson's disease [IPD], abnormal birth history (7/15), and dystonia occurring prior to levodopa therapy (10/15). In six patients, the mean duration of disease until the initiation of levodopa therapy was 14. 2 years, as compared with 4. 1 years in our control population of IPD. The slow progression of disease underscores the relatively favorable prognostic significance of HP/HA and its distinction from IPD.

Address correspondence and reprint requests to Dr. Buchman, Rush-Presbyterian-St. Lukes Medical Center, 1725 W. Harrison Street, Chicago, IL 60612.

Received November 17, 1986. Accepted for publication in final form August 12, 1987.




This article has been cited by other articles:


Home page
NeurologyHome page
S. Wijemanne and J. Jankovic
Hemiparkinsonism-hemiatrophy syndrome
Neurology, October 16, 2007; 69(16): 1585 - 1594.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
P. P. Pramstaller, G. Kunig, K. Leenders, M. Kann, K. Hedrich, P. Vieregge, C. G. Goetz, and C. Klein
Parkin mutations in a patient with hemiparkinsonism-hemiatrophy: A clinical-genetic and PET study
Neurology, March 12, 2002; 58(5): 808 - 810.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1988 by AAN Enterprises, Inc.